We use cookies to analyze site traffic and improve your experience.
By accepting, you consent to the use of analytics cookies.

2871:TSENichirei Corporation Analysis

Data as of 2026-06-23 - not real-time

¥2,103.50

Latest Price

5/10Risk

Risk Level: Medium

Executive Summary

Nichirei Corp (2871.T) is trading at ¥2,103.5, comfortably above its 20‑day SMA (¥1,983.5) and 50‑day SMA (¥1,925.1), while still below the 52‑week high of ¥2,178.5, indicating room for upside. Technical momentum is bullish with a MACD histogram of +6.79 and a bullish signal line, and the RSI sits at 65.5, suggesting strength without being overbought. The stock enjoys a stable volume profile and a low beta near zero, which dampens market‑wide volatility exposure, though the 30‑day price volatility is relatively high at ~26%. Fundamentally, revenue is growing at 6.7% YoY, margins are modest but stable, and the forward PE of 8.9 signals cheap valuation relative to earnings growth. The dividend payout ratio of 43% and a 2.45% yield appear sustainable given strong operating cash flow and a payout ratio below 50%. Analyst consensus is a “buy” with a median target price of ¥2,325, implying a modest upside of about 5% from current levels. The company’s diversified food, logistics, and bioscience operations in a consumer‑defensive sector provide resilience, while its Japanese base limits geopolitical risk. Overall, the blend of bullish technicals, reasonable valuation, and solid dividend sustainability supports a positive outlook.
Given the modest upside, low beta, and defensive industry positioning, the stock is best viewed as fairly valued with a slight undervaluation bias. The combination of stable cash generation, a healthy dividend, and analyst optimism makes it a compelling candidate for investors seeking steady returns with limited downside risk.

Market Outlook

Short Term

< 1 year
Positive
Model confidence: 7/10

Key Factors

  • Bullish MACD and RSI indicating upward momentum
  • Support level well below current price offering downside cushion
  • Stable volume and low beta reducing short‑term volatility

Medium Term

1–3 years
Positive
Model confidence: 8/10

Key Factors

  • Analyst consensus buy with median target price above current level
  • Sustainable dividend yield and payout ratio
  • Modest revenue growth and improving forward PE

Long Term

> 3 years
Positive
Model confidence: 8/10

Key Factors

  • Defensive consumer sector providing resilience in economic cycles
  • Diversified business lines across food, logistics, and bioscience
  • Strong cash flow generation supporting dividend continuity

Key Metrics & Analysis

Financial Health

Revenue Growth6.70%
Profit Margin3.82%
P/E Ratio19.3
ROE9.94%
ROA4.61%
Debt/Equity40.98
P/B Ratio1.8
Op. Cash Flow¥48.7B
Free Cash Flow¥7.5B

Technical Analysis

TrendBullish
RSI65.5
Support¥1,775.50
Resistance¥2,178.50
MA 20¥1,983.48
MA 50¥1,925.09
MA 200¥1,888.70
MACDBullish
VolumeStable
Fear & Greed Index86

Valuation

Fair Value¥237.33
Target Price¥2,216.67
Upside/Downside5.38%
GradeFair
TypeBlend
Dividend Yield2.45%

Risk Assessment

Beta-0.05
Volatility25.96%
Sector RiskLow
Reg. RiskMedium
Geo RiskLow
Currency RiskMedium
Liquidity RiskLow

This analysis may contain inaccuracies and is provided for informational and research purposes only. It is not personal investment advice, a recommendation, or an instruction to buy, sell, or hold any asset.